The blood glucose monitoring market (US, Europe, Asia) is comprised of more than 200 million diabetes patients. This population is expected to be in excess of € 8 billion for FY2017e, and has experienced double-digit compound annual growth rates since 1994. The world’s insatiable appetite for unhealthy processed foods dictates that diabetes rates will continue to escalate, globally and it is strongly anticipated that the growth will continue for the foreseeable future. While the market is currently dominated by The Big 4 players, NIRLUS remains the only company that has successfully developed a real-time non-invasive blood sugar monitoring technology.

Vision: A world where diabetics can enjoy the same quality of life as those who are unaffected by this debilitating disease.

Mission: Improving the health and wellbeing of diabetics by enabling permanent, painless and effortless blood sugar monitoring.